Patients Rely on Ads for GLP-1 Drug Information
Most patients surveyed prefer clinical guidance, yet 73% rely on commercial advertisements for drug information.
Updated on Oct. 27, 2026 in Weight Loss
Live Poll
Do you trust clinical advice more than commercial advertisements when researching new medical treatments?
Between November 2024 and April 2025, researchers at Temple University surveyed 52 patients to assess their awareness of GLP-1 medications and the drugs' influence on household dynamics. The study highlights how media exposure shapes patient perceptions of these treatments.
Why it matters
Understanding how patients interpret medical information from advertisements is essential for clear communication about the use of GLP-1 drugs for obesity and other conditions. This research underscores a disconnect between public perception and clinical guidance in Philadelphia households.
This survey of 52 adult clinic patients with a mean age of 38.9 years found high awareness of GLP-1 drugs, with 98% recognizing the medications. The extent to which these perceptions influence long-term health outcomes remains unknown.
The players
Temple University
A research institution that led the study on patient medication awareness and household health behaviors in Philadelphia.
The details
Researchers recruited participants from four Philadelphia outpatient clinics to evaluate knowledge gaps regarding GLP-1 receptor agonists. While participants were widely aware of these drugs, their understanding of the medications' indicated uses varied, with 88% believing they treat obesity and 43% associating them with blood pressure management. Additionally, 40% of the study group reported current or past personal use of these treatments.
Timeline
The survey on GLP-1 knowledge took place from November 2024 to April 2025.
Health Landscape
This study tracks the public knowledge gap emerging alongside the rapid rise of GLP-1 receptor agonist prescriptions. It serves as a reminder that clinical guidance is often competing with heavy commercial advertising in the patient decision-making process.
If you are considering GLP-1 medications, prioritize information provided by your physician over details found in commercial advertisements. Discussing your specific health goals and the clinical evidence for these drugs is a vital step in making an informed care decision.
The takeaway
Commercial media plays a significant role in shaping how patients perceive modern medical treatments. When evaluating new medication options, always bring specific questions about the evidence to your primary care physician.
Further reading
For more on managing expectations around new treatments, visit our Weight Loss section.
Source note: This article includes information reported by Medscape.
Live Poll
Do you trust clinical advice more than commercial advertisements when researching new medical treatments?
